RE:RE:RE:RE:PMN to Present at the 2022 International AD/PDTM Conferenceho hum...just more presentations...this has been going on for way too long. i would prefer to read about successful clinicals and USDA approval dates. Milestone dates on PMN310 development and others have come and gone and investor interest is waning. This company needs to deliver shareholder value and not smoke and mirrors. jmo